A Phase I Study of Oral Uracil-Tegafur Prior to Weekly Intravenous Gemcitabine in Patients with Advanced Pancreatic Cancer-Reference-Cited by-同舟云学术

A Phase I Study of Oral Uracil-Tegafur Prior to Weekly Intravenous Gemcitabine in Patients with Advanced Pancreatic Cancer

Published:2006 Issue:2 Volume:52 Page:98-102
ISSN:0009-3157
Container-title:Chemotherapy
language:en
Short-container-title:Chemotherapy

Author:

Tanno Satoshi,Nakano Yasuhiro,Osanai Manabu,Koizumi Kazuya,Izawa Tsutomu,Habiro Atsuya,Mizukami Yusuke,Yanagawa Nobuyuki,Fujii Tsuneshi,Okumura Toshikatsu,Kohgo Yutaka

Publisher

S. Karger AG

Subject

Infectious Diseases,Pharmacology (medical),Drug Discovery,Pharmacology,Oncology,General Medicine

Reference17 articles.

1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

2. UFT Is More Antineoplastic against Gastric Carcinoma than 5-Fluorouracil, 1-(2-Tetrahydrofuryl)-5-fluorouracil and 1-Hexylcarbamoyl-5-Fluorouracil

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in oral delivery of anti-cancer prodrugs;Expert Opinion on Drug Delivery;2016-07-06

2. Pancreatic Ductal Adenocarcinomas in Long-Term Follow-Up Patients With Branch Duct Intraductal Papillary Mucinous Neoplasms;Pancreas;2010-01

3. Phase I/II Study of 24-Hour Infusion of Irinotecan Combined with Oral UFT for Metastatic Colorectal Cancer;Chemotherapy;2008

4. Efficacy of Gemcitabine for Locally Advanced Pancreatic Cancer: Comparison with 5-Fluorouracil-Based Chemoradiotherapy;Chemotherapy;2008

5. Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study;Chemotherapy;2007-12-10